These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7803295)

  • 1. Over-expression of the MDM2 gene is found in some cases of haematological malignancies.
    Quesnel B; Preudhomme C; Oscier D; Lepelley P; Collyn-d'Hooghe M; Facon T; Zandecki M; Fenaux P
    Br J Haematol; 1994 Oct; 88(2):415-8. PubMed ID: 7803295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of MDM2 amplification in human leukaemia.
    Ridge SA; Dyer M; Greaves MF; Wiedemann LM
    Br J Haematol; 1994 Feb; 86(2):407-9. PubMed ID: 8199038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the MDM2 oncogene in leukemia and lymphoma.
    Watanabe T; Ichikawa A; Saito H; Hotta T
    Leuk Lymphoma; 1996 May; 21(5-6):391-7, color plates XVI following 5. PubMed ID: 9172803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities.
    Møller MB; Nielsen O; Pedersen NT
    Mod Pathol; 1999 Nov; 12(11):1010-6. PubMed ID: 10574597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53, MDM2, p21waf1, bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma.
    Brynes RK; Wilson CS; Kim AB; McCourty A
    Mod Pathol; 1997 Nov; 10(11):1120-7. PubMed ID: 9388063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearrangement and expression of MDM2 oncogene in chronic lymphocytic leukemia.
    Huang YQ; Raphael B; Buchbinder A; Li JJ; Zhang WG; Friedman-Kien AE
    Am J Hematol; 1994 Oct; 47(2):139-41. PubMed ID: 8092130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin.
    Watanabe T; Hotta T; Ichikawa A; Kinoshita T; Nagai H; Uchida T; Murate T; Saito H
    Blood; 1994 Nov; 84(9):3158-65. PubMed ID: 7949188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S; Takami K; Nakayama T; Nishisho I
    Br J Cancer; 1997; 75(9):1302-8. PubMed ID: 9155050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
    Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
    J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
    Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
    Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes.
    Preudhomme C; Quesnel B; Vachee A; Lepelley P; Collyn-D'Hooghe M; Wattel E; Fenaux P
    Leukemia; 1993 Aug; 7(8):1291-3. PubMed ID: 8350630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
    J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A.
    Elnenaei MO; Gruszka-Westwood AM; A'Hernt R; Matutes E; Sirohi B; Powles R; Catovsky D
    Haematologica; 2003 May; 88(5):529-37. PubMed ID: 12745272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.
    Pagnano KB; Vassallo J; Lorand-Metze I; Costa FF; Saad ST
    Am J Hematol; 2001 Jun; 67(2):84-92. PubMed ID: 11343379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the c-mpl proto-oncogene in human hematologic malignancies.
    Vigon I; Dreyfus F; Melle J; Viguié F; Ribrag V; Cocault L; Souyri M; Gisselbrecht S
    Blood; 1993 Aug; 82(3):877-83. PubMed ID: 8393355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studies.
    Küpper M; Joos S; von Bonin F; Daus H; Pfreundschuh M; Lichter P; Trümper L
    Br J Haematol; 2001 Mar; 112(3):768-75. PubMed ID: 11260082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MDM2 oncogene is rarely amplified in human lymphoid tumors and does not correlate with p53 gene expression.
    Cesarman E; Liu YF; Knowles DM
    Int J Cancer; 1994 Feb; 56(3):457-8. PubMed ID: 8314334
    [No Abstract]   [Full Text] [Related]  

  • 19. MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue. Comparative study with p53 expression.
    Martinez JC; Mateo M; Sánchez-Beato M; Villuendas R; Orradre JL; Algara P; Sánchez-Verde L; García P; López C; Martínez P
    J Pathol; 1995 Sep; 177(1):27-34. PubMed ID: 7472776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
    Fuchs O; Provaznikova D; Kocova M; Kostecka A; Cvekova P; Neuwirtova R; Kobylka P; Cermak J; Brezinova J; Schwarz J; Markova J; Salaj P; Klamova H; Maaloufova J; Lemez P; Novakova L; Benesova K
    Blood Cells Mol Dis; 2008; 40(3):401-5. PubMed ID: 18182175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.